Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combining Esketamine and Prolonged Exposure for PTSD
NCT06795659Phase 2Completed
- Sponsor
- UT Health San Antonio
- Start
- Jun 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of esketamine in post-traumatic stress disorder (PTSD), sponsored by UT Health San Antonio. Started Jun 2025; status: completed.
02
Drugs
esketamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06795659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06795659.